{
  "sections": [
    {
      "title": "Clinical Significance",
      "requirement_evaluations": [
        {
          "requirement_id": "R1",
          "applicable": true,
          "applicability_reasoning": "This section describes the clinical significance of mutations or deficiencies in the gene or protein.",
          "score": 1.0,
          "confidence": 0.95,
          "evidence": "PTSD and metabolic disorder associations with ADCYAP1 are listed.",
          "reasoning": "The section thoroughly explains the diseases linked to the ADCYAP1 gene.",
          "overlap_notes": "There is no unnecessary repetition in this context."
        },
        {
          "requirement_id": "R4",
          "applicable": true,
          "applicability_reasoning": "The section provides in-depth information about studies related to clinical significance.",
          "score": 1.0,
          "confidence": 0.95,
          "evidence": "Studies cited explain the gene's influence on PTSD and metabolism.",
          "reasoning": "The section effectively presents research findings on the clinical relevance of the gene.",
          "overlap_notes": "There is a focus on significance without redundancy."
        },
        {
          "requirement_id": "R5",
          "applicable": true,
          "applicability_reasoning": "All statements regarding clinical significance must be verifiable.",
          "score": 1.0,
          "confidence": 0.95,
          "evidence": "Citations are provided for all claims regarding PTSD and metabolic conditions.",
          "reasoning": "The information is well-supported with reliable references.",
          "overlap_notes": "No overlap detected."
        }
      ],
      "meta_notes": "The section provides a comprehensive view of ADCYAP1's clinical significance with proper references and clarity."
    }
  ]
}